CN109690312A - 生物标记特征和其用途 - Google Patents

生物标记特征和其用途 Download PDF

Info

Publication number
CN109690312A
CN109690312A CN201780035793.2A CN201780035793A CN109690312A CN 109690312 A CN109690312 A CN 109690312A CN 201780035793 A CN201780035793 A CN 201780035793A CN 109690312 A CN109690312 A CN 109690312A
Authority
CN
China
Prior art keywords
sle
biomarkers
amount
test sample
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780035793.2A
Other languages
English (en)
Chinese (zh)
Inventor
卡尔·鲍里贝克
帕扬·德尔法尼
琳达·德克林·梅尔比
克里斯特·韦格伦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immune Media Co Ltd
Original Assignee
Immune Media Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Media Co Ltd filed Critical Immune Media Co Ltd
Publication of CN109690312A publication Critical patent/CN109690312A/zh
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/104—Lupus erythematosus [SLE]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
CN201780035793.2A 2016-06-07 2017-06-07 生物标记特征和其用途 Pending CN109690312A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1609951.7A GB201609951D0 (en) 2016-06-07 2016-06-07 Biomarkers signatures and uses thereof
GB1609951.7 2016-06-07
PCT/EP2017/063855 WO2017211896A1 (en) 2016-06-07 2017-06-07 Biomarker signatures of systemic lupus erythematosus and uses thereof

Publications (1)

Publication Number Publication Date
CN109690312A true CN109690312A (zh) 2019-04-26

Family

ID=56508210

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780035793.2A Pending CN109690312A (zh) 2016-06-07 2017-06-07 生物标记特征和其用途

Country Status (12)

Country Link
US (2) US20200041504A1 (https=)
EP (1) EP3465209A1 (https=)
JP (1) JP2019526810A (https=)
KR (1) KR20190038791A (https=)
CN (1) CN109690312A (https=)
AU (1) AU2017277583A1 (https=)
BR (1) BR112018075223A2 (https=)
CA (1) CA3026574A1 (https=)
GB (1) GB201609951D0 (https=)
MX (1) MX2018015140A (https=)
RU (1) RU2018142846A (https=)
WO (1) WO2017211896A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201014837D0 (en) 2010-09-07 2010-10-20 Immunovia Ab Biomarker signatures and uses thereof
JP7248788B2 (ja) * 2018-10-18 2023-03-29 オクラホマ メディカル リサーチ ファウンデーション 疾患活動性を特徴付ける全身性エリテマトーデス（ｓｌｅ）疾患活動性免疫指標のバイオマーカー
GB201904472D0 (en) * 2019-03-29 2019-05-15 Immunovia Ab Methods, arrays and uses thereof
CN118948243B (zh) * 2024-07-23 2025-10-17 中国医科大学附属第一医院 基于机器学习对神经精神狼疮进行影像组学诊断的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130288912A1 (en) * 2010-09-07 2013-10-31 Immunovia Ab Biomarker signatures and uses thereof
WO2015067969A2 (en) * 2013-11-11 2015-05-14 Immunovia Ab Method, array and use thereof
WO2015189591A2 (en) * 2014-06-09 2015-12-17 Immunovia Ab Methods and arrays for use in the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0039578B1 (en) 1980-05-02 1985-04-10 Edward P. Davis Leg aid device
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5856090A (en) 1994-09-09 1999-01-05 The Scripps Research Institute DNA-methylase linking reaction
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
US20070141627A1 (en) * 2005-10-19 2007-06-21 Behrens Timothy W Systemic Lupus Erythematosus
WO2014008426A2 (en) * 2012-07-06 2014-01-09 Ignyta, Inc. Diagnosis of systemic lupus erythematosus
US20160223537A1 (en) * 2013-09-11 2016-08-04 Singapore Health Services Pte Ltd Identification of novel biomarkers of flares of systemic lupus erythematosus
EP3204766A4 (en) * 2014-10-07 2018-03-21 University Health Network Urinary biomarkers for sle and lupus nephritis

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130288912A1 (en) * 2010-09-07 2013-10-31 Immunovia Ab Biomarker signatures and uses thereof
WO2015067969A2 (en) * 2013-11-11 2015-05-14 Immunovia Ab Method, array and use thereof
WO2015189591A2 (en) * 2014-06-09 2015-12-17 Immunovia Ab Methods and arrays for use in the same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANDERS CARLSSON 等: "Serum Protein Profiling of Systemic Lupus", 《MOLECULAR & CELLULAR PROTEOMICS》 *
CHRISTER WINGREN 等: "Multiplexing of Miniaturized Planar Antibody Arrays for Serum Protein Profiling –", 《LAB ON A CHIP》 *
杨朝菊 等: "SLE患者胱抑素和超敏C-反应蛋白水平与自身抗体的相关性", 《疑难病杂志》 *

Also Published As

Publication number Publication date
US20230063017A1 (en) 2023-03-02
MX2018015140A (es) 2019-08-16
US20200041504A1 (en) 2020-02-06
AU2017277583A9 (en) 2019-08-01
KR20190038791A (ko) 2019-04-09
RU2018142846A3 (https=) 2020-09-16
CA3026574A1 (en) 2017-12-14
EP3465209A1 (en) 2019-04-10
JP2019526810A (ja) 2019-09-19
WO2017211896A1 (en) 2017-12-14
AU2017277583A1 (en) 2019-01-03
GB201609951D0 (en) 2016-07-20
BR112018075223A2 (pt) 2019-03-19
RU2018142846A (ru) 2020-07-09
WO2017211896A9 (en) 2019-03-14

Similar Documents

Publication Publication Date Title
Pillebout et al. Biomarkers of IgA vasculitis nephritis in children
US20220214344A1 (en) Method, array and use thereof
US10859572B2 (en) Biomarker signatures and uses thereof
JP5684724B2 (ja) 強直性脊椎炎を有する患者における抗−ＴＮＦα抗体に対する臨床応答を予測する血清マーカー
JP6661607B2 (ja) 多様体および超平面を用いる生物学的データのコンピュータ分析
JP7584486B2 (ja) 乾癬性関節炎の疾患活動性を評価するためのバイオマーカーおよび方法
US20230063017A1 (en) Biomarker signatures of systemic lupus erythematosus and uses thereof
CN111479934A (zh) 用于诊断和治疗监测的生物学指标的鉴定和用途
Arvey et al. Age-associated changes in the circulating human antibody repertoire are upregulated in autoimmunity
US20230074480A1 (en) Biomarker signatures of systemic lupus erythematosus and uses thereof
US20120178100A1 (en) Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis
Fabian et al. A current state of proteomics in adult and pediatric inflammatory bowel diseases: a systematic search and review
Mestrovic et al. Precision medicine in inflammatory bowel disease: a spotlight on emerging molecular biomarkers
CN107709991A (zh) 用于诊断眼表炎症和干眼病的方法和装置
Sato et al. In-depth serum proteomics by DIA-MS with in silico spectral libraries reveals dynamics during the active phase of systemic juvenile idiopathic arthritis
Czajkowska et al. Are matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 useful as markers in diagnostic management of children with newly diagnosed ulcerative colitis?
Mais et al. HE4 tissue expression as a putative prognostic marker in low-risk/low-grade endometrioid endometrial cancer: a review
Mazur et al. SDS electrophoresis on gradient polyacrylamide gels as a semiquantitative tool for the evaluation of proteinuria
Noack et al. Serum markers Associated with Disease Severity in a Bosnian hemorrhagic fever with renal syndrome cohort
Khatri et al. Serological comparison of systemic lupus erythematosus with neuropsychiatric lupus using synthetic nucleic acid antigens
US20220163524A1 (en) Methods, arrays and uses thereof for diagnosing or detecting an autoimmune disease
Zaripova et al. Systemic Sclerosis in Kazakh Patients: A Preliminary Case–Control Immunogenetic Profiling Study
Zhang et al. Significance of integrated clinical and proteomic characteristics analysis for pathogenesis and management of Crohn's disease with concomitant psoriasis
Ding et al. Predicting Development of Lupus Nephritis for Patients with Systemic Lupus Erythematosus: A Prospective Cohort Study of CSTAR

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190426

WD01 Invention patent application deemed withdrawn after publication